Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST‐Elevation Myocardial Infarction
Background Coronary microvascular dysfunction (CMD) predicts mortality after ST‐elevation–myocardial infarction (STEMI). Arginine vasopressin (AVP) may be implicated, but data in humans are lacking, and no study has investigated the link between arginine vasopressin and invasive measures of CMD. Met...
Main Authors: | Ayman Al‐Atta, Luke Spray, Ashfaq Mohammed, Evgeniya Shmeleva, Ioakim Spyridopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.030473 |
Similar Items
-
Microvascular Obstruction in Acute Myocardial Infarction, a Potential Therapeutic Target
by: Mina Ghobrial, et al.
Published: (2023-09-01) -
International prospective cohort study of microvascular angina – Rationale and design
by: Akira Suda, et al.
Published: (2020-12-01) -
Ability of the coronary angiography-derived index of microcirculatory resistance to predict microvascular obstruction in patients with ST-segment elevation
by: Xinyan Wen, et al.
Published: (2024-04-01) -
Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction
by: Sophia Khattak, et al.
Published: (2024-03-01) -
Non-pharmacological Treatment of Refractory Angina and Microvascular Angina
by: Kudrat Rakhimov, et al.
Published: (2020-08-01)